TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 336 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q4 2019. The put-call ratio across all filers is 1.03 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $2,834 | -56.5% | 219 | -53.3% | 0.00% | – |
| Q1 2024 | $6,514 | -2.7% | 469 | 0.0% | 0.00% | – |
| Q4 2023 | $6,693 | -7.7% | 469 | 0.0% | 0.00% | -100.0% |
| Q3 2023 | $7,255 | -16.3% | 469 | -15.0% | 0.00% | 0.0% |
| Q2 2023 | $8,672 | -24.4% | 552 | -20.7% | 0.00% | 0.0% |
| Q1 2023 | $11,470 | +6.9% | 696 | +1.2% | 0.00% | 0.0% |
| Q4 2022 | $10,733 | +257.8% | 688 | +214.2% | 0.00% | – |
| Q3 2022 | $3,000 | -25.0% | 219 | -17.7% | 0.00% | – |
| Q2 2022 | $4,000 | -55.6% | 266 | -58.4% | 0.00% | -100.0% |
| Q1 2022 | $9,000 | +125.0% | 640 | +149.0% | 0.00% | – |
| Q4 2021 | $4,000 | -55.6% | 257 | -54.4% | 0.00% | -100.0% |
| Q3 2021 | $9,000 | -35.7% | 564 | -33.7% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | -41.7% | 851 | -34.3% | 0.00% | -66.7% |
| Q1 2021 | $24,000 | 0.0% | 1,296 | -3.2% | 0.00% | 0.0% |
| Q4 2020 | $24,000 | -41.5% | 1,339 | -41.9% | 0.00% | -50.0% |
| Q3 2020 | $41,000 | +485.7% | 2,303 | +484.5% | 0.01% | +500.0% |
| Q2 2020 | $7,000 | -61.1% | 394 | -67.2% | 0.00% | -66.7% |
| Q1 2020 | $18,000 | -10.0% | 1,200 | +18.2% | 0.00% | 0.0% |
| Q4 2019 | $20,000 | +17.6% | 1,015 | +4.9% | 0.00% | +50.0% |
| Q3 2019 | $17,000 | +21.4% | 968 | +23.6% | 0.00% | 0.0% |
| Q2 2019 | $14,000 | -75.4% | 783 | -71.9% | 0.00% | -77.8% |
| Q1 2019 | $57,000 | – | 2,784 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |